358 articles
Stay up to date with the latest stock market news, analysis, and market-moving events.
Healthcare spending accelerated 7.2% in 2024 while Eli Lilly expands beyond weight-loss drugs with a $7B acquisition of cancer therapy developer Kelonia Therapeutics.
Google reportedly explores partnership with Marvell Technology for custom AI chip development, potentially diversifying from its primary relationship with Broadcom.
Robert Half shares fell 5.1% after Q1 earnings beat expectations but revenue declined 3.8% year-over-year, highlighting ongoing business headwinds despite surpassing analyst forecasts.
Comcast stock tumbled nearly 13% after Deutsche Bank downgraded the media giant despite strong quarterly results, citing future profitability concerns and competitive pressures.
Nasdaq reported Q1 2026 revenue of $1.41B, beating estimates with 13.7% growth driven by AI and cloud solutions in Financial Technology division.
Tesla stock fell 3.7% as CEO Elon Musk announced $25 billion in capital spending for 2026, a $5 billion increase, to accelerate AI and robotics development while warning of negative cash flow.
Commvault stock drops 5.7% to $90.17 after Scotiabank initiates coverage with cautious outlook, citing competitive pressures and concerns about future growth prospects in data protection market.
Wall Street analysts set bold price targets for Meta, Permian Resources, and LifeStance Health, with projected returns ranging from 22% to over 40% based on divergent fundamental strengths.
Wall Street analysts express caution on Atkore, Plexus, and Murphy Oil as these companies face revenue declines, margin compression, and operational efficiency challenges across different sectors.
LSI Industries surpassed Q1 2026 expectations with $150.5M revenue (+13.6% YoY) and $0.28 EPS, beating analyst forecasts and driving 10.3% stock surge.
Federal Reserve's delicate balance between inflation control and employment stability could determine spring stock market direction amid rising oil prices and geopolitical tensions.
Analysis of three cash-rich companies reveals how balance sheet strength doesn't always indicate investment quality, with regional bank outperforming transportation and medical device peers.
Get the latest stock market news and analysis delivered to your inbox.
No spam, unsubscribe anytime. See our Privacy Policy.
We use cookies to enhance your browsing experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies.